Vibalogics, a CDMO specialising in the production of virotherapy products, has expanded its North American team with strategic hires, including a Chief Financial Officer, VP of Quality and Head of Process Sciences.
The recruitments are aimed to accelerate the redevelopment and opening of Vibalogics’ late-phase and commercial virotherapy manufacturing facility in Boxborough, MA.
Mike DiMeo joins the executive board as CFO, while Judith Adair McCorry has joined as VP of Quality, and Hao (Max) Qian as Head of Process Sciences.
With 15 years’ experience in finance for companies in the life sciences sector, Mike aims to support and drive Vibalogics’ expansion strategy in North America. He has worked for companies including Thermo Fisher Scientific and Exosome Diagnostics.
Judith brings 20 years’ experience in quality assurance, working for multinational biopharma brands including Merck and Emergent BioSolutions. In her role as VP of Quality Judith will be responsible for all facets of quality.
She will be responsible for preparing the Boxborough facility for approval by the FDA. Once the site is operational, Judith will focus on implementing strategies to accomplish the company's quality and compliance goals, while ensuring the CDMO meets regulatory requirements for phase appropriate manufacturing.
As Head of Process Sciences, Max will lead the development and innovation of cutting-edge manufacturing processes for new projects. He brings more than 24 years of experience in the pharmaceutical sector, and 14 years in the biologics space, having worked at Merck, Agilent Technologies, and Abbott Laboratories. His insight will be relied on to help support customers to develop efficient and effective protocols for their late-phase projects.
Tom Hochuli, CEO of Vibalogics, said: “Mike, Judith and Max are fantastic additions to our team here in Boxborough. They all bring with them exceptional skills and experience that will complement our existing team as we bring the new site online, and they will help ensure that we continue to exceed our customers’ rigorous quality expectations into the future.”